AMH, anti-Mullerian hormone, 268

N. diseases: 242; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.080 Biomarker phenotype BEFREE Medical treatment with dienogest significantly reduces endometrioma diameter and associated pain, whereas the ovarian reserve appears to be preserved, with a significant improvement of AFC and no significant change in AMH. 31304853 2020
CUI: C0030193
Disease: Pain
Pain
0.080 Biomarker phenotype BEFREE To determine if sex is associated with differences in postoperative pain scores, narcotic consumption, and long-term improvements in pain and disability following minimally invasive lumbar discectomy (MIS LD). 31162188 2019
CUI: C0030193
Disease: Pain
Pain
0.080 GeneticVariation phenotype BEFREE OBJECTIVEThis study aimed to determine if the preoperative Patient-Reported Outcomes Measurement Information System, Physical Function (PROMIS PF) score is predictive of immediate postoperative patient pain and narcotics consumption or long-term patient-reported outcomes (PROs) following minimally invasive transforaminal lumbar interbody fusion (MIS TLIF).METHODSA prospectively maintained database was retrospectively reviewed. 30717042 2019
CUI: C0030193
Disease: Pain
Pain
0.080 Biomarker phenotype BEFREE The objective of this study was to determine patients' perception of iliac crest bone graft (ICBG) harvesting and donor site pain following minimally invasive transforaminal lumbar interbody fusion (MIS TLIF). 31790370 2019
CUI: C0030193
Disease: Pain
Pain
0.080 GeneticVariation phenotype BEFREE However, direct meta-analysis between RCT study and pooled indirect meta-analysis of MIS-TLIF have better pain, disabilities, and complication but no statistically significant difference when compared to LLIF. 28013419 2018
CUI: C0030193
Disease: Pain
Pain
0.080 Biomarker phenotype BEFREE Both MIS TLIF and DLIF provide long-term improvement in pain andfunctional outcomes, with an overall reduction in postoperative narcotic requirement. 29738856 2018
CUI: C0030193
Disease: Pain
Pain
0.080 Biomarker phenotype BEFREE To compare postoperative narcotic consumption and pain scores between multimodal analgesia (MMA) and patient-controlled analgesia (PCA) following minimally invasive transforaminal lumbar interbody fusion (MIS TLIF). 27879573 2017
CUI: C0030193
Disease: Pain
Pain
0.080 GeneticVariation phenotype BEFREE MED and PELD were associated with greater pain-relief effects at 1 month after surgery than MIS-TLIF, but this effect equalized at 3 months postoperatively. 28153616 2017